SMID Q4 2023 Earnings Reports Positive EPS of 004 Revenue Details Unavailable BCE Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage OMC Q1 2026 Earnings EPS Beats Estimates by 179 Phreesia Q1 2026 Earnings Profitability Misses Estimates Despite Stock Uplift XPRO Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions